Trevena (TRVN) Competitors $1.21 +0.06 (+5.22%) As of 09:51 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainSEC FilingsTrendsBuy This Stock TRVN vs. CMND, CERO, ENSC, TCRT, CANF, GLTO, LIXT, SONN, IMCC, and KTTAShould you be buying Trevena stock or one of its competitors? The main competitors of Trevena include Clearmind Medicine (CMND), CERo Therapeutics (CERO), Ensysce Biosciences (ENSC), Alaunos Therapeutics (TCRT), Can-Fite BioPharma (CANF), Galecto (GLTO), Lixte Biotechnology (LIXT), Sonnet BioTherapeutics (SONN), IM Cannabis (IMCC), and Pasithea Therapeutics (KTTA). These companies are all part of the "pharmaceutical products" industry. Trevena vs. Clearmind Medicine CERo Therapeutics Ensysce Biosciences Alaunos Therapeutics Can-Fite BioPharma Galecto Lixte Biotechnology Sonnet BioTherapeutics IM Cannabis Pasithea Therapeutics Trevena (NASDAQ:TRVN) and Clearmind Medicine (NASDAQ:CMND) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, community ranking, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment. Does the media prefer TRVN or CMND? In the previous week, Clearmind Medicine had 1 more articles in the media than Trevena. MarketBeat recorded 1 mentions for Clearmind Medicine and 0 mentions for Trevena. Trevena's average media sentiment score of 0.00 equaled Clearmind Medicine'saverage media sentiment score. Company Overall Sentiment Trevena Neutral Clearmind Medicine Neutral Do analysts prefer TRVN or CMND? Trevena presently has a consensus target price of $5.00, suggesting a potential upside of 313.22%. Given Trevena's stronger consensus rating and higher probable upside, analysts plainly believe Trevena is more favorable than Clearmind Medicine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Trevena 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Clearmind Medicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders hold more shares of TRVN or CMND? 13.6% of Trevena shares are held by institutional investors. Comparatively, 96.1% of Clearmind Medicine shares are held by institutional investors. 2.7% of Trevena shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has preferable earnings & valuation, TRVN or CMND? Clearmind Medicine has lower revenue, but higher earnings than Trevena. Clearmind Medicine is trading at a lower price-to-earnings ratio than Trevena, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTrevena$443K2.36-$40.29M-$47.04-0.03Clearmind MedicineN/AN/A-$5.26M-$1.22-0.79 Does the MarketBeat Community believe in TRVN or CMND? Trevena received 616 more outperform votes than Clearmind Medicine when rated by MarketBeat users. CompanyUnderperformOutperformTrevenaOutperform Votes61668.37% Underperform Votes28531.63% Clearmind MedicineN/AN/A Is TRVN or CMND more profitable? Trevena's return on equity of 0.00% beat Clearmind Medicine's return on equity.Company Net Margins Return on Equity Return on Assets TrevenaN/A N/A -119.55% Clearmind Medicine N/A -129.21%-61.15% Which has more risk & volatility, TRVN or CMND? Trevena has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500. Comparatively, Clearmind Medicine has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500. SummaryTrevena beats Clearmind Medicine on 7 of the 13 factors compared between the two stocks. Get Trevena News Delivered to You Automatically Sign up to receive the latest news and ratings for TRVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TRVN vs. The Competition Export to ExcelMetricTrevenaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.05M$6.40B$5.34B$7.97BDividend YieldN/A2.96%5.44%4.20%P/E Ratio-0.037.1824.9319.01Price / Sales2.36249.45392.61107.65Price / CashN/A65.8538.2534.62Price / Book-0.116.176.604.32Net Income-$40.29M$143.40M$3.23B$248.23M7 Day Performance-5.47%-3.73%-2.50%1.08%1 Month Performance-11.03%12.08%8.34%9.80%1 Year Performance-88.72%-6.68%14.18%4.45% Trevena Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRVNTrevenaN/A$1.21+5.2%$5.00+313.2%-89.2%$1.05M$443,000.00-0.0340Analyst ForecastCMNDClearmind Medicine0.6706 of 5 stars$1.00-0.9%N/A-33.9%$4.27MN/A-0.53N/AGap UpCEROCERo Therapeutics3.7601 of 5 stars$0.79-7.2%$11.00+1,292.4%-99.4%$4.25MN/A0.008Gap DownENSCEnsysce Biosciences0.0405 of 5 stars$2.47-3.9%N/A-75.3%$4.23M$2.23M-0.0910TCRTAlaunos Therapeutics0.0739 of 5 stars$2.85+12.6%N/A-76.7%$4.15M$10,000.000.0040CANFCan-Fite BioPharma1.4884 of 5 stars$1.15+2.2%$14.00+1,117.4%-44.8%$4.07M$674,000.00-0.648GLTOGalecto2.7679 of 5 stars$3.04+1.7%$10.00+228.9%-83.9%$4.02MN/A-0.1640Earnings ReportNews CoverageGap DownLIXTLixte Biotechnology0.3824 of 5 stars$1.27+1.6%N/A-54.9%$4.00MN/A-0.734SONNSonnet BioTherapeutics1.3226 of 5 stars$1.29-5.1%$20.00+1,450.4%N/A$3.96M$1M0.0010Upcoming EarningsGap DownIMCCIM Cannabis0.1502 of 5 stars$1.58-9.0%N/A-61.3%$3.86M$54.03M-0.46340Gap DownKTTAPasithea Therapeutics0.4531 of 5 stars$1.42+1.4%N/A-86.4%$3.79MN/A-0.113Upcoming Earnings Related Companies and Tools Related Companies CMND Alternatives CERO Alternatives ENSC Alternatives TCRT Alternatives CANF Alternatives GLTO Alternatives LIXT Alternatives SONN Alternatives IMCC Alternatives KTTA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TRVN) was last updated on 5/9/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredIt may already be too late… A global energy shift is underway—and lithium is at the center of it. From electric vehicles to grid storage a...Huge Alerts | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevena, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevena With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TRVN Stock Free TRVN Stock Alerts